Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacist-guided darbepoetin dosing in haemodialysis patients
NL-OMON20569Active, not recruiting
- Sponsor
- Franciscus Gasthuis & Vlietland
- Start
- May 2010
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of darbepoetin alfa and Iron in anaemia and end-stage kidney disease (ESKD) (2 arms), sponsored by Franciscus Gasthuis & Vlietland. Started May 2010; status: active, not recruiting.
02
Drugs
darbepoetin alfaIron
03
Conditions
anaemiaend-stage kidney disease (ESKD)
Beyond the preview
Go deeper on NL-OMON20569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20569.